2.3
[]. H Vijay Kumar, et al. Synthesis and antioxidant properties of some novel 5H-dibenz[b,f]azepine derivatives in different in vitro model systems. Eur J Med Chem. 2 Jan;45():2-.
[2]. Olivier Mathieu, et al. Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL- and IFN-γ secretion in epileptic patients: the influence of co-medication. Pharmacol Rep. 2;63():86-94.
[3]. Predrag Lj Dzodi?, et al. Determination of carbamazepine and its impurities iminostilbene and iminodibenzyl in solid dosage form by column high-performance liquid chromatography. J AOAC Int. 2 Jul-Aug;93(4):59-68.
[4]. S M Furst, et al. Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils. Biochem Pharmacol. 993 Mar 24;45(6):267-75.
[5]. S M Furst, et al. Covalent binding of carbamazepine oxidative metabolites to neutrophils. Drug Metab Dispos. 995 May;23(5):59-4.

H32-H4-H4
P264-P27-P273-P33-P39-P5
GHS7,GHS9
![]()